{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:46:18Z","timestamp":1782308778672,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13346-026-02138-1","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:34:20Z","timestamp":1777397660000},"page":"2514-2526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Propellant-free intrawound antibiotic foam for intraoperative antimicrobial prophylaxis"],"prefix":"10.1007","volume":"16","author":[{"given":"Christina","family":"Karavasili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanghyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Boyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmaine","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niora","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golda S.","family":"Gershanok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh M.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-4077","authenticated-orcid":false,"given":"Giovanni","family":"Traverso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"2138_CR1","doi-asserted-by":"publisher","unstructured":"Patel H, Khoury H, Girgenti D, Welner S, Yu H. Burden of Surgical Site Infections Associated with Select Spine Operations and Involvement of Staphylococcus aureus. Surg Infect. Volume 18. Mary Ann Liebert, Inc., publishers;; 2017. pp. 461\u201373. https:\/\/doi.org\/10.1089\/sur.2016.186.","DOI":"10.1089\/sur.2016.186"},{"key":"2138_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/BRS.0000000000003218","volume":"45","author":"J Zhou","year":"2020","unstructured":"Zhou J, Wang R, Huo X, Xiong W, Kang L, Xue Y. Incidence of Surgical Site Infection After Spine Surgery: A Systematic Review and Meta-analysis. Spine. 2020;45:208\u201316. https:\/\/doi.org\/10.1097\/BRS.0000000000003218.","journal-title":"Spine"},{"key":"2138_CR3","doi-asserted-by":"publisher","unstructured":"Chahoud J, Kanafani Z, Kanj S. Surgical Site Infections Following Spine Surgery: Eliminating the Controversies in the Diagnosis. Front Med [Internet]. 2014 [cited 2023 Dec 9];1. https:\/\/www.frontiersin.org\/articles\/https:\/\/doi.org\/10.3389\/fmed.2014.00007. Accessed 9 Dec 2023.","DOI":"10.3389\/fmed.2014.00007"},{"key":"2138_CR4","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1177\/2192568217745512","volume":"8","author":"J Dowdell","year":"2018","unstructured":"Dowdell J, Brochin R, Kim J, Overley S, Oren J, Freedman B, et al. Postoperative Spine Infection: Diagnosis and Management. Glob Spine J. 2018;8:S37\u201343. https:\/\/doi.org\/10.1177\/2192568217745512.","journal-title":"Glob Spine J"},{"key":"2138_CR5","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1016\/j.wneu.2019.07.207","volume":"131","author":"Z Li","year":"2019","unstructured":"Li Z, Liu P, Zhang C, Xu G, Zhang Y, Chang Y, et al. Incidence, Prevalence, and Analysis of Risk Factors for Surgical Site Infection After Lumbar Fusion Surgery: \u22652-Year Follow-Up Retrospective Study. World Neurosurg. 2019;131:e460\u20137. https:\/\/doi.org\/10.1016\/j.wneu.2019.07.207.","journal-title":"World Neurosurg"},{"key":"2138_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3171\/2020.8.SPINE20992","volume":"34","author":"H Ushirozako","year":"2021","unstructured":"Ushirozako H, Hasegawa T, Yamato Y, Yoshida G, Yasuda T, Banno T, et al. Impact of intrawound vancomycin powder on prevention of surgical site infection after posterior spinal surgery. J Neurosurg Spine. 2021;34:656\u201364. https:\/\/doi.org\/10.3171\/2020.8.SPINE20992.","journal-title":"J Neurosurg Spine"},{"key":"2138_CR7","doi-asserted-by":"publisher","first-page":"369","DOI":"10.21037\/jss-23-46","volume":"9","author":"GK-H Shea","year":"2023","unstructured":"Shea GK-H. Drain blockage by topical vancomycin powder\u2014a case report of a potentially catastrophic complication in spine surgery. J Spine Surg AME Publishing Co. 2023;9:369\u201374. https:\/\/doi.org\/10.21037\/jss-23-46.","journal-title":"J Spine Surg AME Publishing Co"},{"key":"2138_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/10773525.2016.1201238","volume":"22","author":"AA Farshad","year":"2016","unstructured":"Farshad AA, Enferadi M, Bakand S, Jamshidi Orak R, Mirkazemi R. Penicillin dust exposure and penicillin resistance among pharmaceutical workers in Tehran, Iran. Int J Occup Environ Health. 2016;22:218\u201323. https:\/\/doi.org\/10.1080\/10773525.2016.1201238.","journal-title":"Int J Occup Environ Health"},{"key":"2138_CR9","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1016\/j.spinee.2018.04.015","volume":"18","author":"C Horii","year":"2018","unstructured":"Horii C, Yamazaki T, Oka H, Azuma S, Ogihara S, Okazaki R, et al. Does intrawound vancomycin powder reduce surgical site infection after posterior instrumented spinal surgery? A propensity score-matched analysis. Spine J Elsevier. 2018;18:2205\u201312. https:\/\/doi.org\/10.1016\/j.spinee.2018.04.015.","journal-title":"Spine J Elsevier"},{"key":"2138_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00586-014-3357-0","volume":"24","author":"N Evaniew","year":"2015","unstructured":"Evaniew N, Khan M, Drew B, Peterson D, Bhandari M, Ghert M. Intrawound vancomycin to prevent infections after spine surgery: a systematic review and meta-analysis. Eur Spine J. 2015;24:533\u201342. https:\/\/doi.org\/10.1007\/s00586-014-3357-0.","journal-title":"Eur Spine J"},{"key":"2138_CR11","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2018.10.FOCUS18470","volume":"46","author":"V Dodson","year":"2019","unstructured":"Dodson V, Majmundar N, Swantic V, Assina R. The effect of prophylactic vancomycin powder on infections following spinal surgeries: a systematic review. Neurosurg Focus Am Association Neurol Surg. 2019;46:E11. https:\/\/doi.org\/10.3171\/2018.10.FOCUS18470.","journal-title":"Neurosurg Focus Am Association Neurol Surg"},{"key":"2138_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1517\/17425247.2012.694865","volume":"9","author":"S Gibaud","year":"2012","unstructured":"Gibaud S, Attivi D. Microemulsions for oral administration and their therapeutic applications. Expert Opin Drug Deliv. 2012;9:937\u201351. https:\/\/doi.org\/10.1517\/17425247.2012.694865.","journal-title":"Expert Opin Drug Deliv"},{"key":"2138_CR13","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3109\/10837450.2016.1148722","volume":"22","author":"K Ita","year":"2017","unstructured":"Ita K. Progress in the use of microemulsions for transdermal and dermal drug delivery. Pharm Dev Technol. 2017;22:467\u201375. https:\/\/doi.org\/10.3109\/10837450.2016.1148722.","journal-title":"Pharm Dev Technol"},{"key":"2138_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s43390-020-00087-4","volume":"8","author":"MJ Karau","year":"2020","unstructured":"Karau MJ, Zhang C, Mandrekar JN, Kohrs NJ, Puleo DA, van Wijnen AJ, et al. Topical vancomycin for treatment of methicillin-resistant Staphylococcus epidermidis infection in a rat spinal implant model. Spine Deform. 2020;8:553\u20139. https:\/\/doi.org\/10.1007\/s43390-020-00087-4.","journal-title":"Spine Deform"},{"key":"2138_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.crhy.2014.09.008","volume":"15","author":"B Dollet","year":"2014","unstructured":"Dollet B, Raufaste C. Rheology of aqueous foams. Comptes Rendus Phys. 2014;15:731\u201347. https:\/\/doi.org\/10.1016\/j.crhy.2014.09.008.","journal-title":"Comptes Rendus Phys"},{"key":"2138_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/600884","volume":"49","author":"TP Lodise","year":"2009","unstructured":"Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;49:507\u201314. https:\/\/doi.org\/10.1086\/600884.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"2138_CR17","unstructured":"David Geffen School of Medicine at UCLA. Serum chemistry reference ranges-rat [Internet]. 2024 [cited 2024 Jul 9]. https:\/\/labs.dgsom.ucla.edu\/dlam\/files\/view\/docs\/diagnostic-lab-services\/private\/serum_chemistry_reference_ranges_rat.pdf. Accessed 9 Jul 2024."},{"key":"2138_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhin.2017.03.004","volume":"96","author":"JM Badia","year":"2017","unstructured":"Badia JM, Casey AL, Petrosillo N, Hudson PM, Mitchell SA, Crosby C. Impact of surgical site infection on healthcare costs and patient outcomes: a systematic review in six European countries. J Hosp Infect. 2017;96:1\u201315. https:\/\/doi.org\/10.1016\/j.jhin.2017.03.004.","journal-title":"J Hosp Infect"},{"key":"2138_CR19","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1016\/j.spinee.2014.03.011","volume":"14","author":"O Emohare","year":"2014","unstructured":"Emohare O, Ledonio CG, Hill BW, Davis RA, Polly DW, Kang MM. Cost savings analysis of intrawound vancomycin powder in posterior spinal surgery. Spine J Off J North Am Spine Soc. 2014;14:2710\u20135. https:\/\/doi.org\/10.1016\/j.spinee.2014.03.011.","journal-title":"Spine J Off J North Am Spine Soc"},{"key":"2138_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/neuros\/nyy288","volume":"84","author":"P Texakalidis","year":"2019","unstructured":"Texakalidis P, Lu VM, Yolcu Y, Kerezoudis P, Alvi MA, Parney IF, et al. Impact of Powdered Vancomycin on Preventing Surgical Site Infections in Neurosurgery: A Systematic Review and Meta-analysis. Neurosurgery. 2019;84:569\u201380. https:\/\/doi.org\/10.1093\/neuros\/nyy288.","journal-title":"Neurosurgery"},{"key":"2138_CR21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.artd.2018.07.011","volume":"4","author":"NN Patel","year":"2018","unstructured":"Patel NN, Guild GN, Kumar AR. Intrawound vancomycin in primary hip and knee arthroplasty: a safe and cost-effective means to decrease early periprosthetic joint infection. Arthroplasty Today. 2018;4:479\u201383. https:\/\/doi.org\/10.1016\/j.artd.2018.07.011.","journal-title":"Arthroplasty Today"},{"key":"2138_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2106\/JBJS.17.00459","volume":"100","author":"GH Thompson","year":"2018","unstructured":"Thompson GH, Poe-Kochert C, Hardesty CK, Son-Hing J, Mistovich RJ. Does Vancomycin Powder Decrease Surgical Site Infections in Growing Spine Surgery? A Preliminary Study. J Bone Joint Surg Am. 2018;100:466\u201371. https:\/\/doi.org\/10.2106\/JBJS.17.00459.","journal-title":"J Bone Joint Surg Am"},{"key":"2138_CR23","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jspd.2019.01.005","volume":"7","author":"K Khanna","year":"2019","unstructured":"Khanna K, Valone F, Tenorio A, Grace T, Burch S, Berven S, et al. Local Application of Vancomycin in Spine Surgery Does Not Result in Increased Vancomycin-Resistant Bacteria-10-Year Data. Spine Deform. 2019;7:696\u2013701. https:\/\/doi.org\/10.1016\/j.jspd.2019.01.005.","journal-title":"Spine Deform"},{"key":"2138_CR24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/neuros\/nyw097","volume":"80","author":"S Chotai","year":"2017","unstructured":"Chotai S, Wright PW, Hale AT, Jones WA, McGirt MJ, Patt JC, et al. Does Intrawound Vancomycin Application During Spine Surgery Create Vancomycin-Resistant Organism? Neurosurgery. 2017;80:746\u201353. https:\/\/doi.org\/10.1093\/neuros\/nyw097.","journal-title":"Neurosurgery"},{"key":"2138_CR25","doi-asserted-by":"publisher","first-page":"E264","DOI":"10.1097\/BSD.0000000000001578","volume":"37","author":"Z Pinter","year":"2024","unstructured":"Pinter Z, Honig R, Sebastian A, Nassr A, Freedman B, Yaszemski M, et al. Does Intrawound Vancomycin Decrease Postoperative Surgical Site Infection in Spine Surgery: A Retrospective Case-control Study. Clin Spine Surg. 2024;37:E264\u20138. https:\/\/doi.org\/10.1097\/BSD.0000000000001578.","journal-title":"Clin Spine Surg"},{"key":"2138_CR26","doi-asserted-by":"publisher","first-page":"108222","DOI":"10.1016\/j.clineuro.2024.108222","volume":"239","author":"S-W Choi","year":"2024","unstructured":"Choi S-W, Hwang JY, Baek MJ, Lee JC, Jang H-D, Kim J-H, et al. Effectiveness of vancomycin powder for preventing postoperative spinal infection. Clin Neurol Neurosurg. 2024;239:108222. https:\/\/doi.org\/10.1016\/j.clineuro.2024.108222.","journal-title":"Clin Neurol Neurosurg"},{"key":"2138_CR27","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1097\/BRS.0b013e3181ff2cb1","volume":"36","author":"FA Sweet","year":"2011","unstructured":"Sweet FA, Roh M, Sliva C. Intrawound application of vancomycin for prophylaxis in instrumented thoracolumbar fusions: efficacy, drug levels, and patient outcomes. Spine. 2011;36:2084\u20138. https:\/\/doi.org\/10.1097\/BRS.0b013e3181ff2cb1.","journal-title":"Spine"},{"key":"2138_CR28","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/j.jse.2023.02.129","volume":"32","author":"R Garofalo","year":"2023","unstructured":"Garofalo R, Fontanarosa A, De Giorgi S, Lassandro N, De Crescenzo A. Vancomycin powder embedded in collagen sponge decreases the rate of prosthetic shoulder infection. J Shoulder Elb Surg. 2023;32:1638\u201344. https:\/\/doi.org\/10.1016\/j.jse.2023.02.129.","journal-title":"J Shoulder Elb Surg"},{"key":"2138_CR29","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.jtcvs.2017.06.004","volume":"154","author":"M Kowalewski","year":"2017","unstructured":"Kowalewski M, Raffa GM, Szwed KA, Anisimowicz L. Meta-analysis to assess the effectiveness of topically used vancomycin in reducing sternal wound infections after cardiac surgery. J Thorac Cardiovasc Surg. 2017;154:1320\u2013e13233. https:\/\/doi.org\/10.1016\/j.jtcvs.2017.06.004.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2138_CR30","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1039\/B817543H","volume":"5","author":"S Marze","year":"2009","unstructured":"Marze S, Guillermic RM, Saint-Jalmes A. Oscillatory rheology of aqueous foams: surfactant, liquid fraction, experimental protocol and aging effects. Soft Matter Royal Soc Chem. 2009;5:1937\u201346. https:\/\/doi.org\/10.1039\/B817543H.","journal-title":"Soft Matter Royal Soc Chem"},{"key":"2138_CR31","doi-asserted-by":"publisher","first-page":"042601","DOI":"10.1103\/PhysRevE.97.042601","volume":"97","author":"J-C G\u00e9minard","year":"2018","unstructured":"G\u00e9minard J-C, Pastenes JC, Melo F. Foam rheology at large deformation. Phys Rev E. 2018;97:042601. https:\/\/doi.org\/10.1103\/PhysRevE.97.042601.","journal-title":"Phys Rev E"},{"key":"2138_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/10837450.2020.1863426","volume":"26","author":"D Farkas","year":"2021","unstructured":"Farkas D, K\u00e1llai-Szab\u00f3 N, S\u00e1r\u00e1di-Keszty\u0171s \u00c1, Lengyel M, Magramane S, Kiss \u00c9, et al. Investigation of propellant-free aqueous foams as pharmaceutical carrier systems. Pharm Dev Technol. 2021;26:253\u201361. https:\/\/doi.org\/10.1080\/10837450.2020.1863426.","journal-title":"Pharm Dev Technol"},{"key":"2138_CR33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpharm.2017.03.061","volume":"524","author":"J Mirti\u010d","year":"2017","unstructured":"Mirti\u010d J, Papathanasiou F, Temova Raku\u0161a \u017d, GosencaMatja\u017e M, Ro\u0161kar R, Kristl J. Development of medicated foams that combine incompatible hydrophilic and lipophilic drugs for psoriasis treatment. Int J Pharm. 2017;524:65\u201376. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.03.061.","journal-title":"Int J Pharm"},{"key":"2138_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.colsurfa.2015.01.019","volume":"469","author":"E L\u00e9mery","year":"2015","unstructured":"L\u00e9mery E, Brian\u00e7on S, Chevalier Y, Bordes C, Oddos T, Gohier A, et al. Skin toxicity of surfactants: Structure\/toxicity relationships. Colloids Surf Physicochem Eng Asp. 2015;469:166\u201379. https:\/\/doi.org\/10.1016\/j.colsurfa.2015.01.019.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"2138_CR35","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/600884","volume":"49","author":"TP Lodise","year":"2009","unstructured":"Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients. Clin Infect Dis. 2009;49:507\u201314. https:\/\/doi.org\/10.1086\/600884.","journal-title":"Clin Infect Dis"},{"key":"2138_CR36","unstructured":"Martin JH, Norris R, Barras M, Roberts J, Morris R, Doogue M, et al. Therapeutic Monitoring of Vancomycin in Adult Patients: A Consensus Review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Volume 31. Clin Biochem Rev. Australasian Association for Clinical Biochemistry and Laboratory Medicine; 2010. p. 21."}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02138-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02138-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02138-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:50:20Z","timestamp":1782305420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02138-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2138"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02138-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"9 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal protocols were approved by the MIT Committee on Animal Care (CAC) (Approval Date: 10-7-2024\/Protocol Number: 2207000396).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the submission of a patent application describing the developments reported here. Complete details of all relationships for profit and not for profit for G.T. can be found at the following link:\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}